Hangxiang Wang

6.0k total citations · 1 hit paper
122 papers, 5.0k citations indexed

About

Hangxiang Wang is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Hangxiang Wang has authored 122 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 46 papers in Biomaterials and 44 papers in Biomedical Engineering. Recurrent topics in Hangxiang Wang's work include Nanoparticle-Based Drug Delivery (40 papers), Nanoplatforms for cancer theranostics (38 papers) and RNA Interference and Gene Delivery (27 papers). Hangxiang Wang is often cited by papers focused on Nanoparticle-Based Drug Delivery (40 papers), Nanoplatforms for cancer theranostics (38 papers) and RNA Interference and Gene Delivery (27 papers). Hangxiang Wang collaborates with scholars based in China, Madagascar and Japan. Hangxiang Wang's co-authors include Jianqin Wan, Xiaona Chen, Mohamed Kasim Mohamed Subarkhan, Haiyang Xie, Liqian Zhou, Shusen Zheng, Tongyu Li, Xiao Gong, Jiaping Wu and Yiting Qiao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Hangxiang Wang

118 papers receiving 5.0k citations

Hit Papers

Chemically programmed STING-activating nano-liposomal ves... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
    2023 101 citations Tongyu Li, Hangxiang Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hangxiang Wang China 43 2.0k 1.8k 1.7k 892 732 122 5.0k
Kai Xiao China 33 1.7k 0.9× 1.6k 0.9× 2.2k 1.3× 751 0.8× 864 1.2× 91 4.7k
Swati Biswas India 39 2.1k 1.1× 2.8k 1.6× 2.5k 1.5× 600 0.7× 725 1.0× 151 6.0k
Shixian Lv China 36 1.8k 0.9× 1.5k 0.8× 2.2k 1.3× 561 0.6× 645 0.9× 80 4.1k
Qian Yin China 34 1.5k 0.7× 1.7k 0.9× 1.6k 0.9× 485 0.5× 750 1.0× 108 4.4k
Rong Tong United States 42 1.9k 1.0× 1.8k 1.0× 2.5k 1.5× 1.1k 1.2× 876 1.2× 88 5.1k
Ying Zhao China 32 2.5k 1.2× 1.9k 1.0× 2.3k 1.4× 411 0.5× 877 1.2× 75 5.3k
Xianyi Sha China 38 1.9k 0.9× 2.1k 1.2× 2.7k 1.6× 551 0.6× 625 0.9× 98 5.3k
Yun‐Long Wu China 48 2.5k 1.3× 1.6k 0.9× 2.1k 1.2× 819 0.9× 1.2k 1.7× 190 6.5k
Jianbin Tang China 42 3.1k 1.6× 2.4k 1.3× 2.4k 1.4× 657 0.7× 1.4k 1.9× 142 6.8k
Yuanpei Li United States 38 2.9k 1.5× 2.1k 1.2× 2.8k 1.6× 688 0.8× 1.2k 1.7× 121 6.0k

Countries citing papers authored by Hangxiang Wang

Since Specialization
Citations

This map shows the geographic impact of Hangxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangxiang Wang more than expected).

Fields of papers citing papers by Hangxiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangxiang Wang. The network helps show where Hangxiang Wang may publish in the future.

Co-authorship network of co-authors of Hangxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hangxiang Wang. A scholar is included among the top collaborators of Hangxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangxiang Wang. Hangxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Lulu, et al.. (2024). STING‐Activating Small Molecular Therapeutics for Cancer Immunotherapy. ChemBioChem. 25(19). e202400255–e202400255. 4 indexed citations
2.
Chen, X.M., et al.. (2024). Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors. Cancer Research. 84(18). 3044–3057. 30 indexed citations
3.
Zhu, Hai‐Liang, et al.. (2024). A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies. Acta Biomaterialia. 191. 398–411. 3 indexed citations
4.
Li, Xiaoyan, et al.. (2023). A solar-driven interfacial evaporator for seawater desalination based on mussel-inspired superhydrophobic composite coating. Carbon. 217. 118593–118593. 39 indexed citations
5.
Chen, Yu, et al.. (2023). Deep Learning Based Underground Sewer Defect Classification Using a Modified RegNet. Computers, materials & continua/Computers, materials & continua (Print). 75(3). 5455–5473. 11 indexed citations
6.
Gong, Xiao, Haiyang Yu, Xiaona Chen, Peirong Xu, & Hangxiang Wang. (2023). Superhydrophobic PDMS/PPy-Ag/Graphene/PET films with highly efficient electromagnetic interference shielding, UV shielding, self-cleaning and electrothermal deicing. Materials Today Physics. 34. 101076–101076. 30 indexed citations
7.
Shi, Xiaowei, Min-Wen Wang, Jie Yao, et al.. (2023). Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models. Advanced Science. 10(15). e2204890–e2204890. 28 indexed citations
8.
9.
10.
Yang, Zhentao, Haiyang Xie, Jianqin Wan, et al.. (2023). A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation. EBioMedicine. 92. 104594–104594. 4 indexed citations
11.
12.
Li, Tongyu, Xiaona Chen, Jianqin Wan, et al.. (2021). Akt inhibition improves the efficacy of cabazitaxel nanomedicine in preclinical taxane-resistant cancer models. International Journal of Pharmaceutics. 607. 121017–121017. 6 indexed citations
13.
14.
Ren, Lulu, Yuchen Wang, Tao Fang, et al.. (2020). Niacin-ligated platinum(iv)–ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicityin vivo. Chemical Communications. 56(20). 3069–3072. 24 indexed citations
15.
Xie, Binbin, Jianqin Wan, Xiaona Chen, Weidong Han, & Hangxiang Wang. (2019). Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies. Molecular Cancer Therapeutics. 19(3). 822–834. 49 indexed citations
16.
Subarkhan, Mohamed Kasim Mohamed, Lulu Ren, Binbin Xie, et al.. (2019). Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo. European Journal of Medicinal Chemistry. 179. 246–256. 135 indexed citations
17.
Han, Weidong, Binbin Xie, Yiran Li, et al.. (2019). Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer. Theranostics. 9(24). 7458–7473. 90 indexed citations
18.
Chen, Chao, et al.. (2018). Facile one-pot nanocatalysts encapsulation of palladium–NHC complexes for aqueous Suzuki–Miyaura couplings. New Journal of Chemistry. 42(6). 4624–4630. 9 indexed citations
19.
20.
Wang, Hangxiang, Zhongjie Lu, Lijiang Wang, et al.. (2017). New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity. Cancer Research. 77(24). 6963–6974. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Xiao Breakdown of academic impact, for papers by Swati Biswas Breakdown of academic impact, for papers by Shixian Lv Breakdown of academic impact, for papers by Qian Yin Breakdown of academic impact, for papers by Rong Tong Breakdown of academic impact, for papers by Ying Zhao Breakdown of academic impact, for papers by Xianyi Sha Breakdown of academic impact, for papers by Yun‐Long Wu Breakdown of academic impact, for papers by Jianbin Tang Breakdown of academic impact, for papers by Yuanpei Li
Rankless by CCL
2026